IB
ADMA icon

Intrust Bank’s ADMA Biologics ADMA Stock Holding History

Intrust Bank’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,290
Closed -$261K – 408
2025
Q4 		$261K Sell
14,290
-2,320
-14% -$39.1K 0.02% 356
2025
Q3 		$244K Sell
16,610
-4,687
-22% -$80.3K 0.02% 365
2025
Q2 		$388K Sell
21,297
-11,025
-34% -$225K 0.03% 300
2025
Q1 		$641K Sell
32,322
-4,175
-11% -$72.2K 0.06% 200
2024
Q4 		$626K Sell
36,497
-3,841
-10% -$72.3K 0.06% 211
2024
Q3 		$806K Buy
40,338
+9,036
+29% +$141K 0.08% 181
2024
Q2 		$350K Buy
31,302
+5,975
+24% +$50.1K 0.04% 298
2024
Q1 		$167K Buy
25,327
+1,106
+5% +$6.04K 0.02% 384
2023
Q4 		$109K Buy
24,221
+9,992
+70% +$37K 0.01% 379
2023
Q3 		$50.9K Buy
+14,229
New +$54.8K 0.01% 366

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Intrust Bank's ADMA Position: Q1 2026 in Review

Intrust Bank sold out of ADMA Biologics (ADMA) in Q1 2026, closing a stake of 14,290 shares — an estimated $261K sold.

Intrust Bank first reported a position in ADMA in Q3 2023 and held it in 10 quarters. The position peaked at $806K in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Intrust Bank reported no remaining ADMA Biologics position as of Q1 2026 after selling out during the quarter.
  • Intrust Bank sold 14,290 ADMA Biologics shares in Q1 2026, an estimated $261K.
  • Intrust Bank first reported a position in ADMA Biologics in Q3 2023 and held it in 10 quarters.
  • Intrust Bank's ADMA Biologics position peaked at $806K in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.